Schizophrenia: all 3,539 studies
Page 33 of 36. Open to participants first (473), then studies with results posted, then the rest; newest registration first within each.
- Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With RisperdalTerminatedNCT00314613Phase 4
- Risperdal Consta and Health Care Utilization in Patients With SchizophreniaCompletedNCT00313391Phase 4
- Effectiveness of Targeted Cognitive Training for Neurological Deficits in People With SchizophreniaCompletedNCT00312962Phase 1/2
- Effectiveness of an Interactive Educational Website for Improving the Quality of Mental Health Care for People With SchizophreniaCompletedNCT00312949Not applicable
- Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and QuetiapineCompletedNCT00312598
- A Clinical Trial on the Antipsychotic Properties of CannabidiolCompletedNCT00309413Phase 2
- Risperidone Alone Vs. Risperidone Plus Valproate in the Treatment of Patients With Schizophrenia and HostilityCompletedNCT00308360Phase 4
- Graduated Recovery Intervention Program for Enhancing Treatment for First-Episode PsychosisCompletedNCT00307216Not applicable
- Safety and Effectiveness of Sustained Release Bupropion in Treating Individuals With Schizophrenia Who SmokeCompletedNCT00307203Phase 4
- Identification and Treatment of the Liability to Develop SchizophreniaStatus unknownNCT00305474Phase 4
- Effect of Quetiapine on Negative Symptoms and CognitionCompletedNCT00305422Phase 3
- Acute Psychosis Treatment in the Long Term, Unitary Group Study (APLUS)CompletedNCT00304655Phase 4
- SWitching to Abilify Trial (SWAT)CompletedNCT00304616Phase 4
- Fast Titration in the Treatment of Schizophrenia, TaiwanCompletedNCT00304473Phase 3
- The Effect of Cigarette Holders, Plastic Menthol Cigarettes, and Cognitive Behavioral Therapy for Smoking Reduction Among Schizophrenia Inpatients: A Comparative StudyCompletedNCT00302432Not applicable
- Effect Of Talnetant Versus Risperidone Versus Placebo On Psychotic Symptoms In Schizophrenic PatientsCompletedNCT00300963Phase 2
- A Study of Adjunctive Treatment of Aripiprazole in Schizophrenic PatientsCompletedNCT00300846Phase 4
- Trial of Cognitive Behavioral Therapy for SchizophreniaStatus unknownNCT00300651Phase 3
- Effect of Specific Anti-Toxoplasmatic Add-on Medication in Toxoplasma Gondii Seropositive Individuals With Schizophrenia or Major DepressionCompletedNCT00300404Phase 3
- High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective DisorderCompletedNCT00297947Phase 2/3
- A Study of How Long it Takes a Patient to Relapse After Switching From an Oral Antipsychotic to One of Two Doses of Long-acting Risperidone Injections in Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT00297388Phase 3
- The Impact of Quetiapine on the Drug Abuse Patterns of Addicted Schizophrenic PatientsCompletedNCT00295412Phase 4
- Behavioral Treatment of Drug Abuse in Severe and Persistent Mental Illness (SPMI) PatientsCompletedNCT00295139Not applicable
- Cognitive Remediation for SchizophreniaCompletedNCT00295048Not applicable
- A Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres (e-STAR)CompletedNCT00294008
- A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric PracticesCompletedNCT00292409Phase 3
- Enhancing the Prospective Prediction of PsychosisCompletedNCT00291200
- Appetite Increase in Schizophrenia Patients Treated With Atypical AntipsychoticsCompletedNCT00290121Phase 4
- Risperidone Augmentation in Patients With SchizophreniaCompletedNCT00289861Phase 4
- Quantifying Abnormalities in Cortical Activation Associated With Auditory Hallucinations Using Functional Magnetic Resonance ImagingCompletedNCT00288340Not applicable
- Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid MetabolismCompletedNCT00287820Phase 4
- Study of Amantadine for Weight Stabilization During Olanzapine TreatmentCompletedNCT00287352Phase 1
- Treatment Effects From Aerobic Endurance Training and Maximal Strength Training in Patients Suffering From SchizophreniaCompletedNCT00286299Not applicable
- A Registry of Treatment Adherence for Patients With SchizophreniaCompletedNCT00283517
- Aripiprazole in the Treatment of Acutely Relapsed Patients With SchizophreniaCompletedNCT00283179Phase 3
- Alcohol Use Disorders in SchizophreniaCompletedNCT00280813Not applicable
- ECT Schizophrenia Serotonin StudyStatus unknownNCT00278668
- Sarcosine Preventive Therapy for Individuals At High Risk for SchizophreniaWithdrawnNCT00276263Phase 2
- Risperidone LA Heathcare Resource StudyCompletedNCT00272597Phase 4
- CARE Study: Improving Treatment for the Most Severely Ill With SchizophreniaCompletedNCT00272584Phase 4
- Chronic Schizophrenia With Obsessive-Compulsive Symptoms: Comorbidity or a Subtype?CompletedNCT00269464
- SPECT Study With SB-773812 In Schizophrenic PatientsCompletedNCT00269035Phase 1
- Glycine Treatment of Prodromal SymptomsCompletedNCT00268749Phase 2
- Study Evaluating SCA-136 in Subjects With Acute Exacerbations of SchizophreniaCompletedNCT00265551Phase 2
- ADH.E.R.E.: Therapeutic ADHerence and Treatment Strategies: A Mental Health RegistryCompletedNCT00264069
- Cognitive Remediation for SchizophreniaCompletedNCT00261794Not applicable
- A 2-year Study of Patients With Schizophrenia Who Are Treated With Long-acting Injectable Risperidone.CompletedNCT00261430Phase 4
- SB-773812 Administered In Adults With SchizophreniaCompletedNCT00259870Phase 2
- An Exploratory Study on the Safety and Effectiveness of Paliperidone in Patients With SchizophreniaCompletedNCT00257023Phase 2
- Investigation of the Drug Dimethoxbenzylidene Anabaseine in Treating Schizophrenia PatientsCompletedNCT00255918Phase 1
- Seroquel® Combined With Cognitive Remediation Therapy to Conventional Treatment in Patients With SchizophreniaCompletedNCT00255515Phase 4
- Rapid Dose Escalation of Quetiapine Versus Conventional Escalation in Acute Schizophrenic PatientsCompletedNCT00254787Phase 2
- Safety and Efficacy of Seroquel in First Episode SchizophreniaCompletedNCT00254241Phase 4
- Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health PopulationCompletedNCT00253240
- A Study of the Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With SchizophreniaCompletedNCT00253136Phase 3
- A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective DisorderCompletedNCT00253110Phase 4
- A Study to Evaluate the Safety and Efficacy of Clozapine in Patients With Treatment-resistant SchizophreniaCompletedNCT00250575Phase 3
- A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic SchizophreniaCompletedNCT00249223Phase 3
- A Study of Risperidone in Combination With Lorazepam Compared With Standard Therapy for Emergency Treatment of Schizophrenic PatientsCompletedNCT00249171Phase 4
- A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic SchizophreniaCompletedNCT00249132Phase 3
- A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic SchizophreniaCompletedNCT00249119Phase 3
- The Genetic Basis of Inherited Neurologic Deficits in People With SchizophreniaCompletedNCT00247637
- A Study of the Effectiveness and Safety of Risperidone in the Treatment of Adolescents With SchizophreniaCompletedNCT00246285Phase 3
- An Open-label Study Evaluating the Maintenance of Clinical Effect in Adult Schizophrenia Patients Switched From Risperidone Tablets to an Equivalent Dose of a Rapidly-dissolving Tablet Formulation of RisperdoneCompletedNCT00246272Phase 3
- Observational Study in Patients With Schizophrenia Treated With Long-Acting Risperidone Injection (RISPERDAL CONSTA)CompletedNCT00246194
- SOLIACS: Solian Solution in the Acute SettingCompletedNCT00245674Phase 4
- Side Effects of Newer Antipsychotics in Older AdultsCompletedNCT00245206Phase 4
- A Study of the Efficacy and Safety of Long-acting Injectable Risperidone and Risperidone Tablets in Patients With SchizophreniaCompletedNCT00240708Phase 3
- Recovery Therapy TrialCompletedNCT00239122Not applicable
- Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia.CompletedNCT00239109Phase 4
- A Study of Aripiprazole in the Management of Patients With Schizophrenia in the General Psychiatric PracticesCompletedNCT00237939Phase 3
- Schizophrenia Trial of AripiprazoleCompletedNCT00237913Phase 3
- Aripiprazole Treatment of Prodromal PatientsCompletedNCT00237874Phase 2/3
- Effectiveness of Atypical Versus Conventional Antipsychotics in Treating SchizophreniaCompletedNCT00237861Phase 4
- D-Serine for Enhancing Cognitive Retraining for the Treatment of SchizophreniaCompletedNCT00237848Phase 3
- A Long Term Study of Long-acting Injectable Risperidone in the Treatment of Patients With SchizophreniaCompletedNCT00236587Phase 3
- Evaluation of the Usefulness to Doctors of the Risperdal Consta Treatment Guidebook Over a Three-month Period During Which Adult Patients With Schizophrenia or Schizoaffective Disorder Are Switching From Daily Doses or Risperidone Tablets to Long-acting Risperidone by InjectionCompletedNCT00236548Phase 3
- A Study Comparing the Efficacy of Long-acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT00236457Phase 3
- A Study of the Effects of Risperidone and Olanzapine on Blood Glucose (Sugar) in Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT00236379Phase 4
- Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With Schizophrenia or Schizoaffective DisorderCompletedNCT00236353Phase 3
- Trial of Ampakine Added to Clozapine, Olanzapine or Risperidone in Patients With SchizophreniaCompletedNCT00235352Phase 2/3
- Effects of RG1068 (Secretin) on Information Processing in SchizophreniaCompletedNCT00235274Phase 2
- Seroquel Switching Study: Feasibility of Switching Any Antipsychotic Treatment to Seroquel in Patients With SchizophreniaCompletedNCT00234377Phase 3
- A Switch Study of BMS-337039 in Schizophrenic Out-patientsCompletedNCT00232687Phase 4
- Efficacy of Galantamine to Treat SchizophreniaTerminatedNCT00232349Phase 4
- Efficacy and Safety Study of Escitalopram Augmentation in Treatment Resistant SchizophreniaCompletedNCT00231335Phase 4
- Quetiapine Decreases Smoking in Patients With Chronic SchizophreniaStatus unknownNCT00231101Not applicable
- Patient-reported Outcomes in the Treatment of SchizophreniaCompletedNCT00230828Phase 3
- Treatment With Ziprasidone for Schizophrenia Patients With Obsessive Compulsive Disorder (OCD)CompletedNCT00229385Not applicable
- Relapse Prevention, RoW: Study to Evaluate Prevention of Relapse in Patients in Stable Chronic Schizophrenia Receiving Either Seroquel or PlaceboCompletedNCT00228462Phase 3
- Assertive Community Treatment in CopenhagenStatus unknownNCT00225602Not applicable
- The Effects of Aripiprazole on Patients With Metabolic SyndromeCompletedNCT00224822Phase 4
- Medication Adherence in Older Adults With Serious Mental IllnessCompletedNCT00224380Not applicable
- Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective TrialCompletedNCT00224315Phase 4
- Prevalence of Diabetes Mellitus Among Patients Treated With Atypical and Conventional AntipsychoticsCompletedNCT00224276
- Cognitive Remediation and Social Skills Training in SchizophreniaCompletedNCT00223535Not applicable
- Do Self-Report and Physician Impressions of Adherence to Oral Antipsychotic Medication Agree With Objective Data?CompletedNCT00223522
- The Effect of Switching to Aripiprazole on Heart Health in Overweight and Obese Patients With SchizophreniaCompletedNCT00222833Phase 4
- Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes MellitusCompletedNCT00222807
- A Clinical Trial to Examine Effects of Atomoxetine in the Treatment of Negative Symptoms in Patients With SchizophreniaCompletedNCT00222794Phase 4